A phase I clinical and pharmacokinetic study of the camptothecin glycoconjugate, BAY 38-3441, as a daily infusion in patients with advanced solid tumors
| Autor: | Mross, K., Richly, H., Schleucher, N., Korfee, S., Tewes, M., Scheulen, M.E., Seeber, S., Beinert, T., Schweigert, M., Sauer, U., Unger, C., Behringer, D., Brendel, E., Haase, C.G., Voliotis, D., Strumberg, D. * |
|---|---|
| Zdroj: | In Annals of Oncology August 2004 15(8):1284-1294 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|